Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 12, 1997, Pages 3335-3344

  Khaper, Neelam ^a   Rigatto, Claudio ^a   Seneviratne, Charita ^a   Li, Timao ^a   Singal, Pawan K ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Antioxidants; Lipid peroxidation; Reperfusion recovery; blockade

Indexed keywords

ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATALASE; CATECHOLAMINE; GLUTATHIONE PEROXIDASE; MESSENGER RNA; PROPRANOLOL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALIA;

EID: 0031445041     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0558     Document Type: Article

References (42)

1. AUST SD, 1985. Lipid peroxidation. In: Handbook of Methods for Oxygen Radical Research. Boca Raton: CRC Press, 203-207.
2. BOLLI R, 1988. Oxygen derived free radicals and postischemic myocardial dysfunction (stunned myocardium). J Am Coll Cardiol 12: 239-249.
3. BOND PA, 1967. Metabolism of propranolol (Inderal), a potent, specific β-adrenergic receptor blocking agent. Nature 213: 721.
4. CHIRGWIN J, PRYZBYLA A, MACDONALD R, RUTTER W, 1979. Isolation of biologically active ribonucleic acids from sources enriched with ribonuclease. Biochemistry 18: 5294-5299.
5. CLAIBORNE A, 1985. Catalase activity. In: Handbook of Methods for Oxygen Radical Research. Boca Raton: CRC Press, 283-284.
6. CONNALLY ME, KERSTING F, DOLLERY CT, 1976. The clinical pharmacology of beta-adrenoceptor-blocking drugs. Prog Cardiovasc Dis 19: 203-234.
7. COWAN DB, WEISEL RD, WILLIAMS WG, MICKLE DAG, 1992. The regulation of glutathione peroxidase gene expression by oxygen tension in cardiomyocytes. J Mol Cell Cardiol 24: 423-433.
8. DHALIWAL H, KIRSHENBAUM LA, RANDHAWA AK, SINGAL PK, 1991. Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol 261 (Heart Circ Physiol 30): H632-H638.
9. EDOUTE Y, SANAN D, LOCHNER A, GRANEY D, KOTEZ JCN, 1981. Effects of propranolol on myocardial ultrastructure, mitochondrial function and high energy phosphates of isolated working rat hearts with coronary artery ligation. J Mol Cell Cardiol 13: 619-639.
10. FANTINI GA, YOSHIOKA Y, 1992. Use and limitations of thiobarbituric acid reaction to detect lipid peroxidation. Am J Physiol 263: H981-H982.
11. FERRARI R, CECONI C, CURELLO S, GUARNIERI C, CALDARERA CM, ALBERTINI A, VISIOLI O, 1985. Oxygen mediated myocardial damage during ischemia and reperfusion. Role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol 17: 937-945.
12. GARLICK PB, RADDA GK, SEELEY PJ, 1979. Studies on acidosis in the ischemic heart by phosphorus nuclear magnetic resonance. Biochem J 184: 547-554.
13. GUPTA M, SINGAL PK, 1989. Higher antioxidant capacity during chronic stable heart hypertrophy. Circ Res 64: 398-406.
14. GUTTERIDGE JMC, 1982. Free-radical damage to lipids, amino acids, carbohydrates and nucleic acids determined by thiobarbituric acid reactivity. Int J Biochem 14: 649-653.
15. HEARSE DJ, 1979. Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol 44: 1115-1121.
16. JOLLY SR, KANE WJ, BAILIE MB, ABRAMS GD, LUCCHESI BR, 1984. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54: 277-285.
17. KAUL N, SIVESKI-ILISKOVIC N, HILL M, SLEZAK J, SINGAL PK, 1993. Free radicals and the heart. J Pharmacol Toxicol Meth 30: 55-67.
18. KOWALUK B, KHAPER N, RIGATTO C, PALACE V, SINGAL PK, 1998. Mechanisms of cardioprotective effects of propranolol against reperfusion injury. In: Mochizuki S, Takeda N, Nagano M and Dhalla NS (eds). Ischemic Heart. Boston: Kluwer Academic Publishers (in Press).
19. KRAMER JH, MAK IT, FREEDMAN AM, WEGLICKI WB, 1991. Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through an anti-radical mechanism. J Mol Cell Cardiol 23: 1231-1244.
20. LAPENA D, CUCCURULLO F, 1993. TBA test and "Free" MDA assay in evaluation of lipid peroxidation and oxidative stress in tissue systems. Am J Physiol 265: H1030-H1032.
21. LIU X, ENGLEMAN RM, AGARWAL HR, DAS DK, 1991. Preservation of membrane phospholipids by propranolol, pindolol and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol 23: 1091-1100.
22. LOWRY OH, ROSENBROUGH NJ, FARR AL, RANDALL RJ, 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.
23. MAK IT, WEGLICKI WB, 1988. Protection by β-blocking agents against free-radical mediated sarcolemmal lipid peroxidation. Circ Res 63: 262-266.
24. MAK IT, ARROYO CM, WEGLICKI WB, 1989. Inhibition of sarcolemmal carbon-centred free radical formation by propranolol. Circ Res 65: 1154-1156.
25. MAK IT, KRAMER JH, FREEDMAN AM, TSE SYH, WEGLICKI WB, 1990. Oxygen radical mediated injury of myocytes-protection by propranolol. J Mol Cell Cardiol 22: 687-695.
26. MARKLUND SL, 1985. Pyrogallol autoxidation. In: Handbook of Methods for Oxygen Radical Research. Boca Raton: CRC Press, 243-247.
27. NAYLER WG, YEPEZ CE, FASSOLD E, FERRARI R, 1978. Prolonged protective effect of propranolol on hypoxic heart muscle. Am J Cardiol 42: 217-225.
28. NAYLER WG, FERRARI R, WILLIAMS A, 1980. Protective effect of pretreatment with verapamil, Nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 46: 242-248.
29. NAYLER WG, GORDON M, STEPHENS DJ, STURROCK WG, 1985. The protective effect of prazosin on the ischemic and reperfused myocardium. J Mol Cell Cardiol 17: 685-699.
30. PAGLIA DE, VALENTINE WN, 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169.
31. QUAN F, KORNELUK RG, TROPAK MB, GRAIEL RA, 1986. Isolation and characterization of the human catalase gene. Nucleic Acids Res 14: 5321-5335.
32. SHAND DG, NUCKOLLS EM, OATES JA, 1970. Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther 11: 112-120.
33. SLEZAK J, TRIBULOVA N, PRISTACOVA J, UHRIK B, THOMAS T, KHAPER N, KAUL N, SINGAL PK, 1995. Hydrogen peroxide changes in ischemic and reperfused heart: cytochemistry, biochemical and X-ray microanalysis. Am J Pathol 147: 772-781.
34. SOMMERS HM, JENNINGS RB, 1972. Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine and propranolol. Arch Intern Med 129: 780-789.
35. STEENBERGEN CE, MURPHY LL, LONDON RE, 1987. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 60: 700-707.
36. SUGAWARA H, TOBISI K, ONODERA S, 1994. Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol. Biochem Pharmacol 47: 887-892.
37. TAMURA Y, CHI L, DRISCOLL EM, HOFF PT, FREEMAN BA, GALLAGHER PK, LUCCHESI BR, 1988. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ Res 63: 944-959.
38. TIEMEIER DC, TILGHMAN SM, LEDER P, 1977. Purification and cloning of a mouse ribosomal gene fragment incoliphage lambda. Gene 2: 173-191.
39. TOLEIKIS PM, GODIN DV, 1995. Alteration of antioxidant status following sympathectomy: differential effects of modified plasma levels of adrenaline and noradrenaline. Mol Cell Biochem 152: 39-49.
40. WERNS SW, LUCCHESI BR, 1988. Leukocytes, oxygen radicals and myocardial injury due to ischemia and reperfusion. Free Radical Biol Med 4: 31-37.
41. XIANG K, COX NJ, HALLEWELL RA, BELI GI, 1987. Multiple tag 1, RFLP at the human manganese dismutase locus on chromosome 6. Nucleic Acids Res 15: 7654-7659.
42. ZIEGELHOFFER A, DAS PK, SHARMA GP, SINGAL PK, DHALLA NS, 1979. Propranolol effects on myocardial ultrastructure and high energy phosphates in anesthetized dogs subjected to ischemia and reperfusion. Can J Physiol Pharmacol 57: 977-986.